| First Author | Parikh D | Year | 2022 |
| Journal | iScience | Volume | 25 |
| Issue | 10 | Pages | 105058 |
| PubMed ID | 36134334 | Mgi Jnum | J:329264 |
| Mgi Id | MGI:7341186 | Doi | 10.1016/j.isci.2022.105058 |
| Citation | Parikh D, et al. (2022) Allograft inflammatory factor-1-like is a situational regulator of leptin levels, hyperphagia, and obesity. iScience 25(10):105058 |
| abstractText | Mouse models enable the study of genetic factors affecting the complex pathophysiology of metabolic disorders. Here, we identify reductions in leptin levels, food intake, and obesity due to high-fat diet, accompanied by increased leptin sensitivity, in mice that harbor the E2a-Cre transgene within Obrq2, an obesity quantitative trait locus (QTL) that includes the leptin gene. Interestingly, loss of allograft inflammatory factor-1-like (AIF1L) protein in these transgenic mice leads to similar leptin sensitivity, yet marked reversal of the obesity phenotype, with accelerated weight gain and increased food intake. Transgenic mice lacking AIF1L also have low circulating leptin, which suggests that benefits of enhanced leptin sensitivity are lost with further impairment of leptin expression due to loss of AIF1L. Together, our results identify AIF1L as a genetic modifier of Obrq2 and leptin that affects leptin levels, food intake, and obesity during the metabolic stress imposed by HFD. |
